Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD).

The CE approved and FDA DeNovo cleared Acarix CADScor® system is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures.

The CADScor system calculates a patient-specific CAD-score non-invasively in less than 10 minutes with 97% confidence.


Comments

Leave a Reply